These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8562338)

  • 1. Correlation between integrin alpha 5 expression and the malignant phenotype of transitional cell carcinoma.
    Saito T; Kimura M; Kawasaki T; Sato S; Tomita Y
    Br J Cancer; 1996 Feb; 73(3):327-31. PubMed ID: 8562338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of human E-cadherin (ECD) correlated with invasiveness of transitional cell cancer in the renal pelvis, ureter and urinary bladder.
    Wakatsuki S; Watanabe R; Saito K; Saito T; Katagiri A; Sato S; Tomita Y
    Cancer Lett; 1996 May; 103(1):11-7. PubMed ID: 8616803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
    Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
    Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of XIAP in the malignant phenotype of transitional cell cancer (TCC) and therapeutic activity of XIAP antisense oligonucleotides against multidrug-resistant TCC in vitro.
    Bilim V; Kasahara T; Hara N; Takahashi K; Tomita Y
    Int J Cancer; 2003 Jan; 103(1):29-37. PubMed ID: 12455050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of FHIT expression in transitional cell carcinoma of the urinary bladder.
    Baffa R; Gomella LG; Vecchione A; Bassi P; Mimori K; Sedor J; Calviello CM; Gardiman M; Minimo C; Strup SE; McCue PA; Kovatich AJ; Pagano F; Huebner K; Croce CM
    Am J Pathol; 2000 Feb; 156(2):419-24. PubMed ID: 10666370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Immune Checkpoint Molecule CD200 Is Associated with Tumor Grading and Metastasis in Bladder Cancer.
    Rexin P; Tauchert A; Hänze J; Heers H; Schmidt A; Hofmann R; Hegele A
    Anticancer Res; 2018 May; 38(5):2749-2754. PubMed ID: 29715095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
    Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.
    Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I
    Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein expression and gene promoter hypermethylation of CD99 in transitional cell carcinoma of urinary bladder.
    Xuan Y; Kim S; Lin Z
    J Cancer Res Clin Oncol; 2011 Jan; 137(1):49-54. PubMed ID: 20217126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
    Kunze E; Wendt M; Schlott T
    Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is quantitative real-time RT-PCR an adjunct to immunohistochemistry for the evaluation of ErbB2 status in transitional carcinoma of the bladder?
    Amsellem-Ouazana D; Bièche I; Molinié V; Elie C; Vieillefond A; Tozlu S; Botto H; Debré B; Lidereau R
    Eur Urol; 2006 Jun; 49(6):1035-42; discussion 1042-3. PubMed ID: 16466848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder.
    Holyoake A; O'Sullivan P; Pollock R; Best T; Watanabe J; Kajita Y; Matsui Y; Ito M; Nishiyama H; Kerr N; da Silva Tatley F; Cambridge L; Toro T; Ogawa O; Guilford P
    Clin Cancer Res; 2008 Feb; 14(3):742-9. PubMed ID: 18245534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of ureteropelvic transitional cell carcinoma with bladder transitional cell carcinoma using an image analyzer.
    Shiina H; Igawa M; Urakami S; Shirakawa H; Ishibe T
    Urol Int; 1996; 56(3):163-8. PubMed ID: 8860737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and clinical significance of Centrosomal protein 55 (CEP55) in human urinary bladder transitional cell carcinoma.
    Singh PK; Srivastava AK; Rath SK; Dalela D; Goel MM; Bhatt ML
    Immunobiology; 2015 Jan; 220(1):103-8. PubMed ID: 25178936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning and expression of uroplakins in transitional cell carcinoma.
    Yuasa T; Yoshiki T; Isono T; Tanaka T; Okada Y
    Adv Exp Med Biol; 2003; 539(Pt A):33-46. PubMed ID: 15088894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary bladder transitional cell carcinogenesis is associated with down-regulation of NF1 tumor suppressor gene in vivo and in vitro.
    Aaltonen V; Boström PJ; Söderström KO; Hirvonen O; Tuukkanen J; Nurmi M; Laato M; Peltonen J
    Am J Pathol; 1999 Mar; 154(3):755-65. PubMed ID: 10079253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human urinary bladder transitional cell carcinomas acquire the functional Fas ligand during tumor progression.
    Chopin D; Barei-Moniri R; Maillé P; Le Frère-Belda MA; Muscatelli-Groux B; Merendino N; Lecerf L; Stoppacciaro A; Velotti F
    Am J Pathol; 2003 Apr; 162(4):1139-49. PubMed ID: 12651606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers.
    Yu Y; Yang JL; Markovic B; Jackson P; Yardley G; Barrett J; Russell PJ
    Clin Cancer Res; 1997 Jul; 3(7):1045-9. PubMed ID: 9815782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder.
    Shiina H; Igawa M; Urakami S; Honda S; Shirakawa H; Ishibe T
    J Clin Pathol; 1996 May; 49(5):395-9. PubMed ID: 8707954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of MDR-1 gene in transitional cell carcinoma and its correlation with chemotherapy response.
    Pu YS; Tsai TC; Cheng AL; Tsai CY; Tseng NF; Su IJ; Hsieh CY; Lai MK
    J Urol; 1996 Jul; 156(1):271-5. PubMed ID: 8648821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.